Navigation Links
ATS Medical Expects Second Quarter Revenue of $16.7 to $16.9 Million
Date:7/7/2008

Revenue from non-mechanical heart valve businesses expected to grow over

150% from 2007 second quarter

MINNEAPOLIS, July 7 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today reported preliminary revenue results for the second quarter ended June 28, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO)

The Company currently expects revenue for the second quarter 2008 to be between $16.7 and $16.9 million, which would represent an increase of approximately 35% over second quarter 2007 revenue of $12.4 million and an increase of approximately 13% compared to the first quarter of 2008. Revenues from products and services other than the Company's mechanical heart valves are expected to exceed $6.0 million, an increase of approximately 18% over the previous quarterly record of $5.1 million set in the first quarter of 2008. The Company expects to release its second quarter results on August 4.

"Our second quarter results were driven by strong revenue growth across all of our product lines and geographies," said Michael Dale, Chairman, President and CEO of ATS Medical. "ATS CryoMaze(TM) surgical ablation revenue is expected to be especially strong, up approximately 220% over the prior year's second quarter and 13% compared to the first quarter of 2008. Revenue from our Heart Valve Therapy product offerings is expected to increase over 10% compared to the second quarter of 2007 and 11% compared to the first quarter of 2008, driven by new product introductions."

"While we continue to seek FDA approv
'/>"/>

SOURCE ATS Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Pennsylvania Medical Society and AARP Criticize Senator Specter for Blocking Bill to Protect Access to Doctors and Improve Medicare
2. AARP, Texas Medical Association Join Forces to Urge Passage of Bill Protecting Access to Doctors and Improving Medicare
3. Rising Medical Solutions, Inc. Expands Its California Managed Care Services to Include Utilization Review Program
4. Owner of Medical Equipment Company Sentenced to 130 Months in Prison for Health Care Fraud
5. Indiana State Medical Association and AARP Urge Reconsideration of Bill to Protect Seniors Access to Doctors and Improve Medicare
6. As I-1000 Signatures are Counted, Washington State Medical Association Opposition to Physician-Assisted Suicide Reiterated
7. VNUS Medical Technologies, Inc. Files Patent Infringement Lawsuits Against Biolitec, Dornier and CoolTouch
8. July 28, 2008: Status of Unlawfully Expelled Ahmadi Medical Students in Pakistan Still Unclear
9. ATS Medical to Participate at the Fourth Annual Collins Stewart Growth Conference
10. Breastfeeding.com Launches First Ever Social Network for Birth-Related Medical Professionals
11. New MagnaBloc™ Product Available from Gradient Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... IQ Formulations , one of the most highly regarded ... U.S., today is commending GNC for taking steps to boost ... herbal supplements.* GNC vowed that its new processes will look ... labeling on its products. , In response to this ... Jay Cohen said: , “In a lightly-regulated industry where ...
(Date:4/1/2015)... April 01, 2015 eMindful , ... expansion of its executive team with the addition of ... officer. , In his new role, Suissa ... user interface across the business and consumer portals. He ... building the company’s online community. His hiring was ...
(Date:4/1/2015)... PA (PRWEB) April 01, 2015 Health ... company and a subsidiary of West Corporation, today launched ... at http://blog.healthadvocate.com and through the Health Advocate ... healthcare consumers get, and stay, healthy. , “We’re pleased ... available to the public,” said Martin Rosen, Executive Vice ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Dr. ... and Distinguished Teaching Professor of the Department of Plastic ... other doctors to review reports of blindness resulting from ... surgery . The group published their study, along with ... Reconstructive Surgery journal. , "We began to see increasing ...
(Date:4/1/2015)... Sheboygan, WI (PRWEB) April 01, 2015 ... or dryness occur, waiting days or weeks for an ... wants. Historically same and next day appointments haven’t been ... Falls area, Forefront Dermatology’s offices have noticed demand for ... , “We realize how important relief or answers ...
Breaking Medicine News(10 mins):Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 2Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 3Health News:Health Advocate Launches New Health and Wellness Blog 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2
... ... 70 Percent, IRVINE, Calif., Oct. 31 Endocare, Inc.,(Nasdaq: ... the,development of minimally invasive technologies for tissue and tumor,ablation, reported ... margins resulted in a reduction,in operating loss in the third ...
... StemCor Systems, Inc., a,medical device company developing ... it has received 510(k) clearance from,the U.S. ... its MarrowMiner(TM),for the harvest of bone marrow. ... clearance of StemCor,s MarrowMiner is a major,accomplishment ...
... Statistical Significance, IRVINE, Calif., Oct. 30 ... Biotech, today,announced that the Phase 3 SPARC trial ... did not meet its primary,efficacy endpoint. "We ... for,satraplatin did not achieve statistical significance. Drug development ...
... NY) Researchers at the Albert Einstein College of ... time that cancers can be successfully treated by targeting ... in the October 31 issue of PloS One, also ... cells before they turn cancerous. , The Einstein researchers ...
... Corporation,(Nasdaq and OMX Nordic Exchange: EPCT) today announced that ... Acumen BioFin Rodman & Renshaw,9th Annual Healthcare Conference on ... New York Palace Hotel in New York. Mr. Talley ... ) The presentation will be available live via ...
... Oct. 30 Florida already allows it. And new,research ... the,authority to independently prescribe prescription drugs, a move which ... in 2006 to,$145 billion by 2012, according to Prescribing ... Information. The study shows that 77% of drug ...
Cached Medicine News:Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 2Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 3Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 4Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 5Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 6Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 7Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 8Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 9Health News:StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System 2Health News:StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System 3Health News:GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial 2Health News:GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial 3Health News:Einstein scientists treat cancer as an infectious disease -- with promising results 2Health News:Einstein scientists treat cancer as an infectious disease -- with promising results 3Health News:EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Health News:EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 3Health News:By 2012, Prescribing Pharmacists Could Influence $145 Billion in Drug Sales 2
(Date:4/1/2015)... April 1, 2015 International Isotopes Inc. (OTCQB: ... year ended December 31, 2014.  The Company reports a ... loss, and positive cash flow for the year ended ... in 2014 was approximately $7.5 million compared to approximately ... approximately 10%.  With the exception of the radiological services ...
(Date:4/1/2015)... 2015 LifeScienceIndustryResearch.com announces ... Industry and 2015 Deep Research Report on ... Pharmaceutical category in its database.  ... basic information, including definition, classification, application, industry ... news analysis, etc. Azithromycin Key Manufacturers Analysis ...
(Date:4/1/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... Glucose Clamp Study. The study will be performed at ... San Antonio and University Health System,s ... Ralph DeFronzo . The glucose clamp is ...
Breaking Medicine Technology:International Isotopes Inc. Announces 2014 Year End Financial Results 2International Isotopes Inc. Announces 2014 Year End Financial Results 3International Isotopes Inc. Announces 2014 Year End Financial Results 4International Isotopes Inc. Announces 2014 Year End Financial Results 5International Isotopes Inc. Announces 2014 Year End Financial Results 6International Isotopes Inc. Announces 2014 Year End Financial Results 7Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 2Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 3
... Reportlinker.com announces that a new market research report is available ... http://www.reportlinker.com/p0324750/Virtual-Pharma.html ... in the pharmaceutical market has slowed – almost to a ... cutting costs in a faltering world economy. ...
... NEW YORK, Nov. 3, 2010 Pfizer Inc. (NYSE: ... public to view and listen to a webcast of ... Primary Care, at the 2010 Annual Credit Suisse Healthcare ... Mountain Standard Time. (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) ...
Cached Medicine Technology:Reportlinker Adds Virtual Pharma 2Reportlinker Adds Virtual Pharma 3Reportlinker Adds Virtual Pharma 4Reportlinker Adds Virtual Pharma 5Reportlinker Adds Virtual Pharma 6
This blanket is ideal for warming the large child or small adult during upper body surgery....
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
Medicine Products: